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Toward an Attention-Based Diagnostic Tool for Patients With 
Locked-in Syndrome 
Damien Lesenfants1,2,3, Dina Habbal1, Camille Chatelle1,4, Andrea Soddu1,5, Steven Laureys1, 
and Quentin Noirhomme1,6,7 
Abstract 
Electroencephalography (EEG) has been proposed as a supplemental tool for reducing clinical misdiagnosis in severely 
brain-injured populations helping to distinguish conscious from unconscious patients. We studied the use of spectral entropy 
as a measure of focal attention in order to develop a motor-independent, portable, and objective diagnostic tool for patients 
with locked-in syndrome (LIS), answering the issues of accuracy and training requirement. Data from 20 healthy volunteers, 
6 LIS patients, and 10 patients with a vegetative state/unresponsive wakefulness syndrome (VS/UWS) were included. 
Spectral entropy was computed during a gaze-independent 2-class (attention vs rest) paradigm, and compared with EEG 
rhythms (delta, theta, alpha, and beta) classification. Spectral entropy classification during the attention-rest paradigm 
showed 93% and 91% accuracy in healthy volunteers and LIS patients respectively. VS/UWS patients were at chance level. 
EEG rhythms classification reached a lower accuracy than spectral entropy. Resting-state EEG spectral entropy could not 
distinguish individual VS/UWS patients from LIS patients. The present study provides evidence that an EEG-based measure 
of attention could detect command-following in patients with severe motor disabilities. The entropy system could detect a 
response to command in all healthy subjects and LIS patients, while none of the VS/UWS patients showed a response to 
command using this system. 
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Introduction 
Locked-in syndrome (LIS) is characterized by severe motor disabilities, including aphonia or severe hypophonia, quadriplegia 
or quadriparesis, together with preserved cognitive abilities allowing for primary and elementary communication code using 
vertical eye movements or blinking.1 According to Bauer et al,2 LIS can be subdivided based on the severity of motor 
impairments: classical LIS is characterized by total immobility except for vertical eye movements or blinking; incomplete LIS 
still shows remnants of voluntary motion; and complete/total LIS consists of complete immobility including all eye movements. 
The two most common causes of LIS are a bilateral ventral pontine lesion following a vascular pathology or a traumatic brain 
injury, and amyotrophic lateral sclerosis, a motor-neuron degenerative disease that can potentially lead to a complete LIS. The 
rarity of locked-in syndrome due to acute ventral lesion often results in the diagnosis being delayed or even missed, and in the 
underestimation of preserved cognitive abilities when these patients are encountered in clinic.3 Difficulties in diagnosis could 
also be explained by the difficulty of recognizing unambiguous signs of consciousness in severely brain injured patients, by the 
apparent similarity with the unresponsive wakefulness syndrome/vegetative state (VS/UWS; ie, eyes opening and motor 
immobility without signs of awareness)4 but also by a possible fluctuation of the arousal level in the acute stage.5 For these 
reasons, a high rate of misdiagnosis is very likely to happen, especially in complete LIS.3,6,7 However, early detection of signs 
of consciousness in LIS is crucial in terms of medical care, rehabilitation and quality of life.3 
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In this context, motor-independent paraclinical tools have been proposed to facilitate the detection of signs of 
consciousness, such as command-following, in the acute stage and improve quality of life in the chronic stage using 
computer-based communication8-11 (for a review, see Naci et al,12 Chatelle et al,13 and Chaudhary et al14). In particular, 
electroencephalography (EEG)-based brain-computer interfaces (BCIs) constitute an interesting approach as they allow 
direct recording of the brain activity without the intervention of behavioral motor responses or invasive surgery.15 The 
successful use of BCIs by large population of healthy users has been reported in several studies.16-20 Alongside, many studies 
have shown that these systems are feasible and practical for patient groups.9,21 However, when studying LIS and complete 
LIS, current EEG-based BCIs suffer from limited accuracy,11,22-24 task complexity,23 motor dependency,9,25 and/or long user 
training.9 Task-related variation of focal attention could be used in such attention-driven paradigm to help probing 
command-following. The ability to sustain attention in a task for a period of time26,27 can be measured with EEG without 
the intervention of behavioral responses.28 Evoked potential response under different attentional levels29-31 and power 
spectral density distribution or the energy changes of specific EEG rhythms32 have been proposed to evaluate the level of 
attention but have never been combined with an attention-based paradigm in brain-injured patients. Entropy originates from 
a measure of information called Shannon entropy33 and is a measure of signal regularity or predictability; usually, a high 
value corresponds to increased irregularity or unpredictability (eg, uniform distribution of the power spectrum), while a low 
value corresponds to high regularity (eg, concentration of the activity in a single band). Approximate,34 permutation,35 and 
spectral36,37 entropy measures have been applied to EEG. Entropy values have been found to decrease consistently from 
wake to sleep with the lowest value occurring during deep sleep.38,39 Entropy has been shown to correlate with anesthetic 
depth.35,37,40-42 It has also been applied to detect epileptic seizures43 and to evaluate the level of consciousness in 
postcomatose patients44-48 but has never been proposed as a measure of attention or vigilance during a task. The interested 
reader will find a more detailed explanation of the link between entropy values and EEG signals in Viertio-Oja et al.37 
The aim of the present work was to propose task-related modification of attention, evaluated using spectral entropy (SpE), 
as a motor-independent tool to detect response to command in severely brain-injured patients. We hypothesized that an 
increase of attention related to the task may be observed in conscious patients (LIS) but not in unconscious patients 
(VS/UWS). 
Materials and Methods 
We analyzed data acquired in our previous study on covert steady-state visually evoked potentials (SSVEP)-based BCI in 
healthy volunteers and patients with LIS.11 In this study, the participants had to concentrate on yellow or red interleaved 
patterns flashing at different frequencies. A classifier was trained on the spectral features to distinguish yellow from red 
trials. An accuracy higher than chance level was seen as proof of the ability of the participant to follow a command and was 
obtained in 20 out of 24 healthy volunteers and 2 out of the 6 LIS patients. In the present study, we randomly selected 20 
healthy volunteers out of the 24, and we added new data acquired in patients with VS/UWS to the initial cohort. We then 
analyzed the difference between rest trials and attention trials (collapsing red and yellow trials), hereinafter named passive 
and active trials, respectively. 
Participants 
Twenty healthy volunteers (6 men; age 28 ± 8 years), 6 LIS patients (2 classical and 4 incomplete; 4 men; age 49 ± 20 years; 
5 with cerebrovascular accident and 1 trauma; interval since insult 8 ± 5 years; see Table 1 for demographic and clinical 
data of patients with LIS) and 10 patients with VS/UWS (6 men; age 43 ± 15 years; interval since insult 3 ± 2 years; see 
Table 2 for demographic and clinical data of VS/UWS patients) participated in this study. None had prior experience with 
EEG-based BCI studies. The study was approved by the ethical committee of the University Hospital of Liege and all 
participants, or their legal representative, provided informed consent. No participants were excluded from the study, and all 
chose to participate. The Coma Recovery Scale–Revised (CRS-R) was used to define the clinical diagnosis of patients with 
VS/UWS. The CRS-R is currently the most sensitive tool for disentangling conscious from unconscious responses following 
a brain injury.49,50 Trained neuropsychologists conducted the CRS-R assessment at least once a day over 5 days, and the best 
score obtained was used to determine the diagnosis. All diagnoses were confirmed with positron emission tomography.51 
Data Collection 
EEG signals were recorded from 12 Ag/AgCl ring electrodes at locations P3, P1, P2, P4, PO7, PO3, POz, PO4, PO8, O1, 
Oz, and O2, referenced to Pz, based on the international 10-20 electrode system. The ground electrode was placed on the 
right mastoid. All impedances were kept less than 5 kohm. Electrooculography was monitored using 4 electrodes: 2 on the 
left and on the right temples; the remaining 2 over and under the supra-orbital ridge. The amplifier used was a BrainVision 
V-Amp with a bandpass filter between 0.01 and 100 Hz and a sampling frequency of 250 Hz. 
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Visual Stimulation 
The visual stimulation was delivered via a custom-made stimulation unit, which can be decomposed into a control unit and 
a stimulation panel. The panel, placed 30 cm away from the participant’s head, was a 7  7cm2 “interlaced squares” made 
of red and yellow 1  1 cm2  
 
 
 
Table 1. Demographic and Clinical Data of Patients With Locked-in Syndrome (LIS). 
 Sex Age (Years) Etiology Intervala MRI Daily Communication Code 
LIS1 Male 47 Brainstem stroke 3 Cerebellar and pontomesencephalic 
lesions 
Verbalization via tracheostomy 
LIS2 Male 74 Brainstem stroke 3 Pontomesencephalic and occipital lesions Yes (head movement) and no 
(eyes closure) communication 
LIS3 Female 56 Brainstem stroke 15 Pontomesencephalic, middle cerebellar, 
and occipital lesions 
Yes-no head movements 
communication 
LIS4 Male 23 Traumatic brainstem lesion 7 Right cerebellar, right frontal and left 
lenticular lesions. Diffuse axonal injury 
in frontal and parietal lobes and the 
lenticular capsula. Global cerebral 
atrophy with quadriventriculaire 
hydrocephalus 
Yes (looks right) and no (eyes 
closure) communication 
LIS5 Female 30 Brainstem stroke 9 Cerebellar and brainstem lesions Yes (eyes closure) and no (looks 
up) communication 
LIS6 Male 64 Brainstem stroke 12 Pontine and diffuse periventricular 
lesions 
Yes-no head movements 
communication 
a Indicates the interval since insult (in years). 
Table 2. Demographic and Clinical Data of VS/UWS Patients. 
 Sex Age Etiology Intervala MRI CRS-R 
VS1 Female 65 Traumatic 1 Global corticosubcortical atrophy with secondary 
hydrocephalus. Cerebral microbleeds in right 
frontal lobe.  
1(Au), 1(Vi), 2(M), 1(Ve), 0(C), 2(Ar) 
VS2 Male 62 Anoxic 2 Global corticosubcortical atrophy with secondary 
hydrocephalus 
1(Au), 0(Vi), 1(M), 1(Ve), 0(C), 1(Ar) 
VS3 Female 38 Anoxic 4 Global corticosubcortical atrophy with secondary 
hydrocephalus 
1(Au), 0(Vi), 1(M), 1(Ve), 0(C), 2(Ar) 
VS4 Male 31 Anoxic 3 Global corticosubcortical atrophy with secondary 
hydrocephalus. Bilateral basal ganglia lesions 
1(Au), 0(Vi), 2(M), 1(Ve), 0(C), 1(Ar) 
VS5 Female 51 Subarachnoid 
hemorrhage 
1 Global corticosubcortical atrophy with secondary 
hydrocephalus. Brainstem posthemorrhage lesions 
1(Au), 0(Vi), 1(M), 2(Ve), 0(C), 1(Ar) 
VS6 Male 51 Subarachnoid 
hemorrhage 
1 Hippocampal, thalamic and corpus callosum 
atrophy.  
1(Au), 0(Vi), 1(M), 1Ve), 0(C), 1(Ar) 
VS7 Male 31 Traumatic 5 Bihemispheric diffuse axonal injury. Brainstem, bifrontal 
and parietal lesions. Global atrophy with secondary 
hydrocephalus 
1(Au), 0(Vi), 1(M), 1(Ve), 0(C), 1(Ar) 
VS8 Female 52 Mixed (traumatic 
and hypoxia) 
1 Global corticosubcortical atrophy with secondary 
hydrocephalus. Bihemispheric diffuse axonal injury 
1(Au), 1(Vi), 2(M), 1(Ve), 0(C), 1(Ar) 
VS9 Male 28 Traumatic 7 Global corticosubcortical atrophy with secondary 
hydrocephalus 
1(Au), 0(Vi), 1(M), 2(Ve), 0(C), 1(Ar) 
VS10 Male 21 Traumatic 1 Bihemispheric diffuse axonal injury. Brainstem, corpus 
callosum, and bitemporal lesions 
1(Au), 1(Vi), 2(M), 1(Ve), 0(C), 1(Ar) 
Abbreviations: VS/UWS, vegetative state/unresponsive wakefulness syndrome; CRS-R, Coma Recovery Scale–Revised. 
a Indicates the interval since insult (in years). 
 
light-emitting diode (LED) squares with a white fixation cross in the middle (see Figure 1). The control unit was an electronic 
embedded system used to control red and yellow flickering frequencies, which can be varied independently between 1 and 
99 Hz by a programmable integrated circuit microcontroller. During the experiment, the yellow and red squares were 
programmed to flicker at 10 and 14 Hz, respectively. 
Paradigms 
A 5-minute recording at rest (resting-state activity, baseline) was collected at the beginning of the experiment. Then, each 
participant underwent a total of 6 runs, each lasting about 5 minutes, composed of ten 7-second active and ten 7-second 
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passive trials (total of 60 active and 60 passive trials). Each 7-second trial was interspersed with an 8-second auditory 
instruction. During active trials, they were asked to look at the fixation cross while focusing their attention on one of the 
flashing colors (total of 30 times on red and 30 times on yellow, in a randomized order). During passive trials, participants 
were instructed to look at the fixation cross. Fixating may require a low level of attention. However, the level of attention 
should increase during active trials. Breaks between runs were offered and varied between participants depending on the 
level of fatigue. 
Patients with LIS and VS/UWS are easily exhausted and can present eye-closure due to fatigue during the session. 
Patients’ eyes were monitored during the recording session and, if prolonged eye-closure was observed, the run was 
interrupted and the arousal facilitation protocol, as established in the CRS-R administration guidelines, was performed 
before resuming the experimental procedure. We decided to reject data  
 
 
 
 
 
Figure 1. Experimental setup. On the left, the electrode locations. We recorded EEG from 12 posterior electrodes in the standard 10/20 
configuration. On the right, the electronic visual stimulation unit: yellow squares (in white) were flashed at a frequency of 10 Hz. Red 
squares were flashed at 14 Hz (in gray). The subject was seated at 30 cm from the display and was instructed to passively look at the white 
cross (ie, passive trials) or to focus his attention on the yellow or red flashes (ie, active trials) while looking at the white cross. X is the 
fixation cross. 
 
 
from these interrupted blocks from the analysis in order to avoid data with patients’ unclear state of arousal, and repeated 
the rejected block as soon as the clinical expert confirmed sustained eye opening. Shortened eye-closure may induce change 
in the frequency spectrum over the occipital cortex, increasing the power in the alpha band. Increased alpha-band power 
may reduce the uniformity of the spectrum and decrease SpE. In order to evaluate the effect of short eye-closures that could 
be observed in healthy volunteers and patients, the eyes-closed and eyes-open effect on the SpE in the passive condition was 
evaluated on 5 healthy volunteers. 
Data Analysis 
Preprocessing: EEG signals were preprocessed with a Butterworth fourth-order bandpass filter with a cutoff frequency of 
0.5 to 60 Hz, and an infinite impulse response notch filter (fc = 50 Hz, Q = 35). 
EEG Features: Spectral Entropy. Multitapers spectral analysis52,53 (7 tapers) was used to extract the power spectrum of each 
channel and on each 7-second active and 7-second passive trial, and to compute the SpE (frequency band: 0.5-32 Hz with a 
0.5-Hz step; 1-second epochs) as defined by Viertio-Oja et al37: 
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where: 
● Pn(fi) is the normalized power spectrum at frequency fi. The normalization process divides each frequency power by 
the sum of all frequency powers. 
● N[f1; f2] is equal to the total number of frequency components in the range [f1; f2]. 
Averaged SpE during each trial was extracted for each channel, resulting in 12 features per trial. To study the modulation 
of SpE between conditions, we also extract the entropy averaged over all electrodes on each second (1-second sliding 
window, no overlap) for each participant. We then computed the mean and standard deviation of the entropy in each 
condition (baseline, passive and active). Note that we computed the baseline entropy values on the whole 5-minute baseline 
recording at the beginning of each session, not on the rest periods between trials. 
Mean SpE within the passive and active trials was computed on the 5 healthy participants participating in the eyes-closed 
versus eyes-open study. 
EEG Features: Frequency Power Analyses. At each electrode location, we extracted mean EEG power spectral 
amplitude with multitapers spectral analysis (7 tapers) in delta (1-4 Hz), theta (4-8 Hz), alpha (8-12 Hz), and beta (12-
30 Hz) bands in nonoverlapping 1-second windows. Averaged EEG power during each trial was extracted for each 
channel, resulting in 12 features per band and per trial. 
Classification and Statistical Analyses. Classification performances between active and passive trials were computed with 
a linear discriminant analysis (LDA), and assessed with a 10  10-fold cross-validation. A permutation test54,55 evaluated 
the chance-level for each participant (1000 repetitions, LDA classification, 10  10-fold cross validation, P < .01). The 
significance of change between conditions (eyes-closed/eyes-open; baseline/passive/active; subject-level and group-level 
difference) was assessed with a non-parametric Wilcoxon signed-rank test (2-tailed, P < .01). All analyses were done with 
custom-made code using MatLab. The BCI2000 software package56 and Fieldtrip Toolbox57 were used for data acquisition 
and presentation of the auditory instructions. 
Effect of Trial Duration on Performance. We estimated the effect of the trial duration on the performance by analyzing 
reduced trials with a duration of 1 to 6 seconds by 1-second increment. All trials started at the beginning of the original 
corresponding trial to replicate online condition, resulting in exactly the same number of trials. The classification procedure 
described above was replicated for the 6 concentration times. The results were compared with the results obtained with the 
full 7-second window with a Wilcoxon signed-rank test. 
Results 
Spectral Entropy and Alpha Power Evolution Over Time 
Spectral entropy waveform shapes during active and passive trials in a representative participant from each group are 
illustrated in Figure 2 (full line). An increase of SpE at the beginning of the instruction of active trials could be observed in 
healthy volunteer and LIS groups, reaching a maximum during the active trial. At the end of the active trial, SpE decreased, 
reaching a minimum during the passive trial. A Wilcoxon signed-rank test indicated that SpE was higher in the active trials 
than in the passive trials for all healthy volunteers (at group level, active, 0.92 ± 0.02; passive, 0.86 ± 0.04; Z = 72.38, P < 
.01; at subject level, all P values were <.01) and all LIS patients (at group level, active, 0.94 ± 0.02; passive, 0.90 ± 0.03; Z 
= 32.78, P < .01; at subject level, all P values were <.01). None of the VS/UWS showed task-related variation of entropy 
between active condition (0.95 ± 0.02) and passive condition (0.95 ± 0.01), Wilcoxon signed-rank test, Z = 0.41, P = .68 
(see Table 3). 
Averaged SpE during rest (baseline) could differentiate healthy volunteers (0.87 ± 0.04; range: 0.81-0.96; see Table 3) 
from VS/UWS (0.94 ± 0.02; range: 0.89-0.96) at group level (Wilcoxon signed-rank test, Z = 49.82, P < .01). We did not 
run group comparison with LIS patients (range: 0.92-0.95) because of the small number of LIS patients. The ranges of values 
computed for each group covered each other, impairing the classification of individual participant into a given group. 
Alpha power modulation over time could be observed between the attention task in all healthy volunteers (a high alpha 
power during passive trials followed by a low alpha power during active trials; Wilcoxon signed-rank test, at group level, Z 
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= 33.79, P < .01; at subject level, all P values were <.01) and 5 out of 6 patients with LIS (Wilcoxon signed-rank test, at 
group level, Z = 76.17, P < .01; at subject level, all P values were <.01, except for patient LIS2 with P = .02, Z = 2.39; see 
Supplementary Figure 1, available at http://eeg.sagepub.com/content/by/ 
supplemental-data). This alpha modulation was absent in all the VS/UWS patients (Wilcoxon signed-rank test, P > .08, Z 
ranging from 0.05 to 2.01). For an illustrative example of the alpha power modulation between conditions, see Figure 2 
(dashed line). Healthy volunteers illustrated higher power (Wilcoxon signed-rank test, P < .01; during active trials, Z = 
37.33; during passive trials, Z = 39.29) in the alpha band (passive, 13.38 ± 11.12 μV2/Hz; active, 1.94 ± 1.76 μV2/Hz) than 
patients with VS/UWS (passive, 1.50 ± 4.09 μV2/Hz; active, 0.36 ± 1.98 μV2/Hz). During the baseline, alpha power was 
more variable than SpE (coefficient of variation, ie, std/mean, range; SpE = 0.02-0.04; alpha = 0.80-6.06), Wilcoxon signed-
rank test, Z = 5.23, P < .01. 
Averaged spectral decomposition of 7-second windows during active and passive trials illustrates the importance of alpha 
band modulation between the active and passive conditions (Figure 3 and Supplementary Figures 2-4). Visually evoked 
potential peaks (see 10 and 14 Hz, and the first harmonics, 20 and 28Hz, in Figure 3) were not discernable from background 
activity, illustrating their low influence on SpE modulation between active and passive conditions as compared with the 
alpha band. For a better view of the EEG power spectrum in the different conditions, please see Figure SM1 in the 
supplementary materials. 
Active Versus Passive Classification 
SpE could differentiate between active and passive conditions with a mean accuracy of 93% ± 1% in the healthy volunteers 
(see Table 4). The patients with LIS achieved similar mean accuracy (91% ± 1%; Wilcoxon signed-rank test, Z = 2.62, P = 
.287), while UWS/VS patients were at chance level (50% ± 3%; see Table 4). All 20 healthy volunteers, all the LIS patients, 
and none of the VS/UWS patients showed accuracy higher than chance-level illustrating a response-to-command 
(permutation test, 1000 permutations, P < .01; see Table 4, column 2). 
For the healthy volunteers, classification of power in the EEG frequency bands at group level reached 62% ± 2% (delta), 
71% ± 2% (theta), 77% ± 2% (alpha), 75% ± 2% (beta), and 76% ± 2% (all bands together). For LIS patients,  
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Figure 2. Time behavior of the SpE (full line) and alpha activity (dashed line), extracted with Multitapers Spectral analysis on 
nonoverlapping 1-second windows and averaged on all 12 posterior electrodes, computed for a representative healthy subject (first row), 
LIS patient (second row) and VS/UWS patient (third row). Dark gray and light gray blocks represent the active and passive trials, 
respectively. For active trials, the instructed color is mentioned on the top of the bloc (R for red; Y for yellow). Intertrials white blocks 
represent the instruction period. Note the increase of SpE during the active trials (as compared with passive and baseline resting-state 
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conditions) in healthy subjects and LIS patient, but not in VS/UWS patients. SpE, spectral entropy; LIS, locked-in syndrome; VS/UWS, 
vegetative state/unresponsive wakefulness syndrome. 
Table 3. Mean ± standard deviation of the spectral entropy in the different conditions (baseline, passive, and active).a 
 Baseline Passive Active P Z 
Subject      
 HV1 0.88 ± 0.03 0.86 ± 0.02 0.9 ± 0.03 <.01 14.41 
 HV2 0.89 ± 0.05 0.88 ± 0.05 0.94 ± 0.02 <.01 16.61 
 HV3 0.90 ± 0.03 0.83 ± 0.03 0.93 ± 0.02 <.01 19.90 
 HV4 0.87 ± 0.03 0.87 ± 0.04 0.92 ± 0.02 <.01 16.37 
 HV5 0.86 ± 0.04 0.83 ± 0.04 0.93 ± 0.02 <.01 19.87 
 HV6 0.88 ± 0.04 0.89 ± 0.04 0.94 ± 0.02 <.01 16.61 
 HV7 0.82 ± 0.03 0.83 ± 0.04 0.90 ± 0.02 <.01 17.22 
 HV8 0.84 ± 0.03 0.83 ± 0.03 0.92 ± 0.02 <.01 19.72 
 HV9 0.85 ± 0.04 0.85 ± 0.03 0.90 ± 0.02 <.01 18.35 
 HV10 0.88 ± 0.03 0.88 ± 0.04 0.92 ± 0.02 <.01 13.43 
 HV11 0.81 ± 0.03 0.81 ± 0.03 0.88 ± 0.02 <.01 17.94 
 HV12 0.89 ± 0.03 0.87 ± 0.03 0.91 ± 0.02 <.01 17.51 
 HV13 0.81 ± 0.05 0.83 ± 0.05 0.92 ± 0.02 <.01 17.56 
 HV14 0.89 ± 0.03 0.87 ± 0.03 0.91 ± 0.02 <.01 16.68 
 HV15 0.86 ± 0.03 0.84 ± 0.03 0.91 ± 0.02 <.01 19.76 
 HV16 0.96 ± 0.01 0.95 ± 0.01 0.96 ± 0.01 <.01 14.64 
 HV17 0.83 ± 0.04 0.83 ± 0.04 0.93 ± 0.02 <.01 19.52 
 HV18 0.82 ± 0.04 0.88 ± 0.05 0.89 ± 0.04 <.01 5.06 
 HV19 0.94 ± 0.02 0.94 ± 0.02 0.94 ± 0.01 <.01 5.40 
 HV20 0.93 ± 0.02 0.91 ± 0.03 0.95 ± 0.01 <.01 16.82 
 LIS1 0.93 ± 0.02 0.88 ± 0.03 0.94 ± 0.02 <.01 13.83 
 LIS2 0.93 ± 0.03 0.93 ± 0.03 0.94 ± 0.02 <.01 3.51 
 LIS3 0.94 ± 0.02 0.90 ± 0.04 0.95 ± 0.01 <.01 13.07 
 LIS4 0.92 ± 0.04 0.86 ± 0.03 0.93 ± 0.03 <.01 17.72 
 LIS5 0.95 ± 0.01 0.94 ± 0.02 0.95 ± 0.01 <.01 8.83 
 LIS6 0.94 ± 0.02 0.91 ± 0.03 0.95 ± 0.01 <0.01 17.00 
 UWS1 0.95 ± 0.01 0.95 ± 0.01 0.95 ± 0.01 .901 0.06 
 UWS2 0.96 ± 0.01 0.95 ± 0.01 0.95 ± 0.01 .983 0.02 
 UWS3 0.95 ± 0.02 0.96 ± 0.02 0.96 ± 0.02 .297 1.04 
 UWS4 0.96 ± 0.01 0.96 ± 0.01 0.96 ± 0.02 .884 0.15 
 UWS5 0.96 ± 0.01 0.96 ± 0.01 0.96 ± 0.01 .264 1.11 
 UWS6 0.92 ± 0.01 0.91 ± 0.01 0.92 ± 0.02 .661 1.41 
 UWS7 0.96 ± 0.01 0.96 ± 0.01 0.96 ± 0.01 .135 1.49 
 UWS8 0.94 ± 0.02 0.94 ± 0.02 0.94 ± 0.02 .536 0.62 
 UWS9 0.89 ± 0.03 0.92 ± 0.02 0.92 ± 0.03 .478 0.71 
 UWS10 0.96 ± 0.01 0.96 ± 0.01 0.96 ± 0.01 .476 0.71 
Group      
 HV 0.87 ± 0.04 0.86 ± 0.04 0.92 ± 0.02 <.01 72.38 
 LIS 0.93 ± 0.02 0.90 ± 0.03 0.94 ± 0.02 <.01 32.78 
 UWS 0.94 ± 0.02 0.95 ± 0.01 0.95 ± 0.02 .68 0.41 
Abbreviations: LIS, locked-in syndrome; VS/UWS, vegetative state/unresponsive wakefulness syndrome; HV, healthy volunteer. 
a The significance of change between the passive and active conditions was assessed with a nonparametric Wilcoxon signed rank-sum test with P < .01 (P 
and associated Z-test statistic are shown in the last 2 columns). 
Table 4. Mean ± standard deviation of classification accuracy (%) obtained with spectral entropy (SpE), all EEG bands (R), alpha (α), 
beta (β), theta (Θ), and delta (δ) analysis in Healthy Volunteers (HV), LIS Patients, and VS/UWS Patients.a 
 SpE R δ Θ α β  
Subject        
 HV1 91 ± 1 84 ± 2 68 ± 2 85 ± 1 80 ± 2 83 ± 1 SpE 
 HV2 97 ± 0 53 ± 4 55 ± 3 51 ± 2 70 ± 3 58 ± 2 SpE 
 HV3 99 ± 0 85 ± 2 63 ± 3 68 ± 2 86 ± 1 81 ± 2 SpE 
 HV4 98 ± 0 74 ± 3 65 ± 2 74 ± 2 75 ± 1 70 ± 2 SpE 
 HV5 99 ± 0 82 ± 2 68 ± 2 77 ± 1 81 ± 2 89 ± 1 SpE 
 HV6 87 ± 1 62 ± 3 55 ± 3 55 ± 3 63 ± 2 57 ± 1 SpE 
 HV7 96 ± 1 85 ± 2 57 ± 4 83 ± 1 90 ± 1 81 ± 2 SpE 
 HV8 98 ± 0 78 ± 1 67 ± 2 78 ± 1 80 ± 1 89 ± 1 SpE 
 HV9 94 ± 1 83 ± 2 72 ± 1 88 ± 2 74 ± 2 74 ± 2 SpE 
 HV10 86 ± 1 70 ± 4 60 ± 2 65 ± 3 68 ± 2 63 ± 2 SpE 
 HV11 99 ± 0 83 ± 2 61 ± 2 78 ± 1 82 ± 1 87 ± 1 SpE 
 HV12 99 ± 0 78 ± 2 56 ± 2 57 ± 2 80 ± 1 82 ± 1 SpE 
 HV13 92 ± 1 75 ± 2 66 ± 2 64 ± 3 71 ± 2 68 ± 3 SpE 
 HV14 97 ± 0 85 ± 1 62 ± 3 89 ± 1 87 ± 1 77 ± 3 SpE 
 HV15 99 ± 0 85 ± 2 61 ± 2 82 ± 1 89 ± 0 86 ± 1 SpE 
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 HV16 86 ± 1 45 ± 3 51 ± 2 46 ± 2 53 ± 3 43 ± 2 SpE 
 HV17 99 ± 0 82 ± 2 59 ± 2 76 ± 1 82 ± 1 75 ± 2 SpE 
 HV18 69 ± 1 64 ± 2 55 ± 3 58 ± 2 56 ± 2 68 ± 2 SpE, β 
 HV19 84 ± 2 81 ± 1 67 ± 2 67 ± 2 70 ± 1 84 ± 1 SpE 
 HV20 99 ± 0 92 ± 1 69 ± 2 86 ± 1 94 ± 1 86 ± 1 SpE 
 LIS1 91 ± 1 77 ± 3 55 ± 3 73 ± 2 78 ± 2 75 ± 2 SpE 
 LIS2 91 ± 2 65 ± 4 73 ± 2 67 ± 4 68 ± 2 87 ± 2 SpE 
 LIS3 91 ± 1 68 ± 6 48 ± 4 77 ± 2 84 ± 1 72 ± 3 SpE 
 LIS4 100 ± 0 94 ± 1 66 ± 2 77 ± 1 95 ± 1 94 ± 1 SpE 
 LIS5 85 ± 1 89 ± 2 67 ± 2 83 ± 1 70 ± 1 70 ± 2 R 
 LIS6 89 ± 1 73 ± 3 68 ± 2 66 ± 2 79 ± 2 62 ± 2 SpE 
 UWS1 54 ± 3 49 ± 4 61 ± 4 56 ± 2 49 ± 4 52 ± 3 — 
 UWS2 48 ± 3 56 ± 3 46 ± 4 47 ± 3 63 ± 3 57 ± 2 — 
 UWS3 49 ± 2 49 ± 3 53 ± 2 51 ± 2 49 ± 4 42 ± 5 — 
 UWS4 49 ± 4 42 ± 6 41 ± 4 51 ± 4 47 ± 5 50 ± 3 — 
 UWS5 50 ± 3 48 ± 3 52 ± 3 52 ± 3 49 ± 4 44 ± 4 — 
 UWS6 44 ± 2 50 ± 3 46 ± 4 50 ± 3 54 ± 3 48 ± 4 — 
 UWS7 47 ± 4 58 ± 2 53 ± 4 60 ± 3 47 ± 4 69 ± 3 β 
 UWS8 54 ± 2 54 ± 3 48 ± 1 50 ± 3 53 ± 2 50 ± 3 — 
 UWS9 47 ± 3 59 ± 3 56 ± 2 37 ± 5 42 ± 3 52 ± 3 — 
 UWS10 56 ± 4 50 ± 4 50 ± 3 55 ± 3 48 ± 3 53 ± 4 — 
Group        
 HV 93 ± 1 76 ± 2 62 ± 2 71 ± 2 77 ± 2 75 ± 2 SpE 
 LIS 91 ± 1 78 ± 2 63 ± 1 74 ± 1 79 ± 1 77 ± 1 SpE 
 UWS 50 ± 3 51 ± 4 52 ± 3 51 ± 3 50 ± 4 52 ± 3 — 
Abbreviations: LIS, locked-in syndrome; VS/UWS, vegetative state/unresponsive wakefulness syndrome. 
a Accuracies above chance level (permutation test, P < .01, 1000 permutations) are shown in bold. The significance of change between the different methods 
was assessed with a nonparametric Wilcoxon signed rank-sum test with P < .01. 
 
 
Figure 3. Representation of EEG time course, corresponding power spectrum and SpE for a patient with LIS. First row: raw EEG time 
course during a passive trial (left) and the corresponding active trial (right). Second row: power spectrum of 7-second active (full line) 
and 7-second passive (dotted line) trial presented in the first row. Third row: SpE time course during the trials presented in the first row 
and the intertrial instruction period (left). SpE for the passive (left) and active (right) trial presented in the first row. Note the increase of 
SpE from the passive trial to the active trial. Instruction period illustrate a transition state between “low-entropy” passive condition and 
“high-entropy” active condition. Healthy volunteer and VS/UWS patient’s figure can be found in the supplementary materials (see Figure 
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SM2-4, available at http://eeg.sagepub.com/content/by/supplemental-data). SpE, spectral entropy; LIS, locked-in syndrome; VS/UWS, 
vegetative state/unresponsive wakefulness syndrome. 
 
Table 5. Comparison of method’s performance on classifying task-related modification of attention (active vs passive) on healthy 
volunteers (white area) and patients with locked-in syndrome (gray area)a: Spectral entropy (SpE), All EEG bands (R), alpha (α), beta 
(β), theta (Θ), and delta (δ). 
 SpE (6) R (2) δ (0) Θ (1) α (4) β (2) 
SpE (6)  SpE SpE SpE SpE SpE 
  (<.01) (<.01) (<.01) (<.01) (<.01) 
R (3) SpE  R R — — 
 (<.01)  (<.01) (<.01) .332 .146 
δ (0) SpE R  Θ α β 
 (<.01) (<.01)  (<.01) (<.01) (<.01) 
Θ (1) SpE R Θ  α β 
 (<.01) (<.01) (<.01)  (<.01) (<.01) 
α (4) SpE — α α  α 
 (<.01) 0.965 (<.01) (<.01)  (<.01) 
β (2) SpE R β β α  
 (<.01) (<.01) (<.01) (<.01) (<.01)  
a Each row and column intersection illustrated the best of the 2 methods with the corresponding P value (Wilcoxon signed rank-sum test, with P < .01). 
All comparison with P > .01 were considered not significant (—). For each method, we mention (on the first row for the LIS; on the first column for the 
HV) the number of outperformed methods. 
 
the performances were 63% ± 1% (delta), 74% ± 1% (theta), 79% ± 1% (alpha), 77% ± 1% (beta), and 78% ± 2% (all bands 
together). The VS/UWS group were at chance level. At the single-subject level, a response-to-command could be observed in 
9/20 HV and 4/6 LIS (delta), 15/20 HV and 6/6 LIS (theta), 17/20 HV and 6/6 LIS (alpha), 17/20 HV and 5/6 LIS (beta), 15/20 
HV and 6/6 LIS (all bands) (permutation test, 1000 permutations, P < .01). All but one VS/UWS patients were at chance-level 
(permutation test, 1000 permutations, all P values were >.05, except for patient VS/UWS7 with 63% accuracy and P < .01; see 
Table 4, columns 3-7). 
A Wilcoxon signed-rank test indicated that EEG-SpE illustrated higher performance than all the other methods in 19 out 
of 20 HV and 5 out of 6 LIS, Z range = 2.81 to 2.88, all P values were <.01. HV18 showed performance similar to SpE with 
beta features (Wilcoxon signed-rank test, Z = 0.24, P = .81). At the group level, EEG entropy classification outperformed 
all 6 other methods with an increase in accuracy ranging from 16% to 31% and from 12% to 28%, respectively, in healthy 
volunteers and LIS patients (Wilcoxon signed-rank test, P < .01; see Table 5). As expected, alpha power features 
outperformed all the other bands, as well as the combination of bands. 
Effect of Trial Duration on Performance 
For healthy volunteers, similar performances were observed with trial of 5, 6, and 7 seconds (Wilcoxon signed-rank test; P 
> .01). For patients with LIS, no significant differences in the performance were observed for 4, 5, 6, and 7 seconds 
(Wilcoxon signed-rank test; P > .01). VS/UWS patients illustrated performance at chance level for all the different duration. 
Evolution of performance with the trial duration in healthy volunteers and patients with LIS are shown in Figure 4. 
 
Eyes-Closed Versus Eyes-Open 
Mean and standard deviation of the SpE averaged on all trials and healthy volunteers, for the eyes-closed versus eyes-open 
study, are shown in Figure 5. For both conditions, entropy increased from passive to active trials. There was no significant 
difference between eyes-open and eyes-closed conditions at single-subject level (Wilcoxon signed-rank test, Z range: 0.13-
2.02, P > .080). 
Discussion 
The present study provides evidence that SpE can support the evaluation of response-to-command in an attention-based 
paradigm. All 20 healthy volunteers and the 6 LIS patients showed evidence of command-following while none of the tested 
VS/UWS patients did. While previous entropy studies in brain-injured population compute difference in the whole 
recording, the present study benefit of single-trial classification of active versus passive trials, opening the door to online 
BCI evaluation of response-to-command. Our measure combined with an attention paradigm enable to get information at 
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single-subject level with higher accuracy than previous entropy studies in this population, only based on EEG resting-state 
activity. 
Measures of EEG signal complexity, such as entropy, were initially developed for anesthesia monitoring. Gosseries et al44 
showed a higher decrease of SpE during resting-state EEG recordings in patients with VS/UWS than minimally conscious state 
(MCS) in comparison with healthy volunteers. SpE could discriminate VS/UWS and MCS patients with a specificity and 
sensitivity of 89% in the acute setting. In chronic patients, however, SpE offered no reliable diagnostic information. 
Approximate entropy at rest also showed reduced complexity in patients with VS/UWS58 and prognostic capability.59 The 
bispectral  
 
 
 
 
 
Figure 4. Evolution of performance with the trial duration in the healthy volunteers (upper) and patients with LIS (lower). Note the 
increasing performance with duration while reaching a plateau after 4 seconds (patients with LIS) and 5 seconds (healthy volunteers). 
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Figure 5. Mean and standard deviation of the spectral entropy (SpE) for the passive (n = 60) and active (n = 60) trials averaged over all 
12 posterior electrodes for 5 healthy subjects. The passive epoch is represented in dark gray and the active epoch in light gray. Note the 
increase in SpE during the active trials (eyes open) as compared with the passive trials acquired in both eyes-open (top) and eyes-closed 
(bottom) condition. 
 
 
index, another measure of signal complexity, was also shown to correlate with scores of the Glasgow Coma Scale,60 and lower 
values at rest were observed in patients with VS/UWS than in patients with MCS.61 However, these differences did not allow 
to distinguish patient’s state at the individual level.62 Similarly, in the present article, averaged entropy measure at rest could 
not disentangle LIS from VS/UWS patients. This may reflect time-dependent cortical reorganization and plasticity already 
observed in brain-injured patients,63 inducing higher entropy in chronic VS/UWS patients than in acute patients. Alternatively, 
it could be related to contamination of the EEG signal by high-frequency muscle artifacts.42 Even if no obvious muscular 
artifacts contamination could be observed in our data, muscular artifacts may increase the entropy by increasing the frequency 
power at several or all frequencies. The short time window, 1 second, used to estimate the entropy, may also results in less 
accurate estimation of the frequency powers. The choice of the window length was based on the decision to track change in 
attention, not the general value of the resting entropy. Estimating the best length of different computation windows for the 
different frequencies, with increased size for the low frequencies and reduced size for the fast frequencies as in the original 
paradigm,44 would have requested a separate data set and will be part of a future study. Further patient studies are also needed 
to determine the robustness of an entropy-based approach to different levels of artifacts. We suppose that no change could be 
observed if the complexity measure is saturated by artifacts. 
All LIS patients included in the present study have a means of communication, some even based on yes-no vocalizations 
or head movements. Furthermore, in this study, no LIS patient was in the acute state, which is the final target population of 
the present system. However, despite regaining residual control of movement over time, chronic LIS patient are the closest 
to the acute settings. The patients included in the present study have enough cognitive ability to communicate but 4 out of 
6 were not able to respond-to-command with our covert SSVEP-BCI.11 In previous attempts to detect command-following 
in patients with LIS, an active auditory oddball task enabled detection of command-following in a complete LIS patient.6 A 
4-choice auditory oddball enabled the detection in 1 LIS out of 2.24 A vibrotactile oddball was tested successfully on 6 
patients with LIS.66 Functional MRI (fMRI) mental imagery was tested successfully on 5 patients with LIS in 2 separate 
studies.51,67 An EEG alternative of the mental imagery paradigm was tested with success in 1 patient with LIS.68 Finally, an 
hybrid P3-SSVEP paradigm detected command-following in 1 patient with LIS.69 Several studies also attempted to 
communicate with LIS patients using brain-computer interface and several training sessions.9,25,70-74 Not all patients were 
able to communicate. The results were influenced by the condition of the patient and the BCI paradigm. Altogether, these 
studies emphasize the potential of EEG and fMRI, when available, to detect command-following. 
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We compared SpE and power spectrum variation in the alpha, beta, theta, and delta bands. Our results illustrated that SpE 
outperformed frequency band analyses at both group and single-subject levels. In particular, only SpE allows detecting a 
response-to-command in all healthy volunteers and LIS patients. This could be explained by the combined use of information 
inside all frequency bands with no prior assumptions. Indeed, although EEG alpha and beta bands have been widely used as a 
marker of attention in healthy volunteers,75 EEG recordings in patients with LIS have been reported to be normal in some 
patients but often show slowing of activity (limited or diffuse) and in some case abnormal patterns like alpha coma.62,76,77 
SpE could be used in other paradigms using active tasks (eg, motor imagery,68 P30023). Combining information from both 
approaches has the advantage of 2 evaluations of response-to-command with a single assessment. Our SpE index could also 
serve as a measure of attention permitting to better characterize BCI performance changes over time, especially relevant in the 
clinical context of severely brain damaged patients, known to frequently show fluctuations in arousal.5 Note that in the present 
study, electrodes in the posterior area were selected for data acquisition of the original SSVEP paradigm. These locations are 
probably suboptimal for the evaluation of SpE. Higher order association areas, such as the frontal areas,33 are known to be 
involved in attentional control and should be examined in future studies. The implementation of a real-time platform should 
also be considered to allow online clinical evaluation with EEG-based entropy measures directly at the patient’s bedside. 
Changes in attention could also be used for single-switch online communication, similarly to Stoll et al78 and Müller-Putz et 
al.79 
Conclusion 
In this study, we examined the use of SpE to improve the detection of command-following in patients with severe motor 
disabilities. This measure (a) needs no prior user training, (b) requires a limited attention span for each trial (4-5 seconds), (c) 
is based on a simple task, and (d) is adapted for use at a patient’s bedside. It may help reduce misdiagnoses between LIS and 
unconscious patients and could offer new prognostic information during the recovery following a coma.80 Future studies could 
try the proposed methodology in patients with a minimally conscious state, showing nonreflexive behavior such as visual 
pursuit but no motor sign of response to command.81 
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